评估喘治疗的有效性是否足够全面?
David A Stempel1, Stanley J Szefler2
1Digital Healthcare, Bellevue, Wash.
The Journal of allergy and clinical immunology
|December 22, 2023
概括
喘指南治疗旨在通过减少喘损伤和恶化来控制疾病. 仅仅在临床试验中专注于减轻恶化,可能无法完全捕捉整体喘控制,特别是在较轻的疾病中.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 喘管理 喘管理
背景情况:
- 喘治疗指南的目标是通过尽量减少损伤和减少恶化风险来控制疾病.
- 在严重喘中使用生物药物的临床试验主要集中在降低恶化率上.
- 最近对轻度喘的试验也使用减轻恶化作为主要目标,通常显示统计学上显著的结果,但样本大小较大.
研究的目的:
- 评估喘疗法在实现全面疾病控制方面的有效性.
- 调查减轻恶化和整体喘损伤之间的关系.
- 突出需要改善喘损伤和潜在不同的治疗点的测量工具.
主要方法:
- 对喘治疗的临床试验目标和结果的分析.
- 在不同喘严重程度的喘减轻率的比较.
- 讨论喘损伤和疾病缓解的测量挑战.
主要成果:
- 减轻恶化是喘生物试验中常见的主要目标,特别是在严重喘中.
- 对较轻度喘的试验显示出明显的恶化减少,但这可能并不总是与减弱相关.
- 与轻度喘相比,严重喘中减轻恶化的程度要大得多.
结论:
- 达到优异的喘控制需要同时改善损伤和恶化领域.
- 减轻恶化和改善损伤之间的脱节可能需要使用替代评估工具或新的治疗机制.
- 评估每日症状对于确定治疗反应和疾病缓解至关重要,特别是在患有严重喘的患者中.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213


